γ knife surgery versus reoperation for recurrent glioblastoma multiforme. (Q48579487)

13 February 2018

title

γ knife surgery versus reoperation for recurrent glioblastoma multiforme. (English)

1 reference

13 February 2018

1 reference

3

1 reference

13 February 2018

author name string

Bente Sandvei Skeie

1

1 reference

13 February 2018

Per Øyvind Enger

2

1 reference

13 February 2018

Jeremy Christopher Ganz

4

1 reference

13 February 2018

Frits Thorsen

5

1 reference

13 February 2018

Jan Ingeman Heggdal

6

1 reference

13 February 2018

Paal-Henning Pedersen

7

1 reference

13 February 2018

publication date

4 April 2012

1 reference

13 February 2018

published in

World Neurosurgery

1 reference

13 February 2018

volume

78

1 reference

13 February 2018

issue

6

1 reference

13 February 2018

page(s)

658-669

1 reference

13 February 2018

Reoperation in the treatment of recurrent intracranial malignant gliomas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

'Recurrent' glioblastoma multiforme, when should we reoperate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Survival and functional status after resection of recurrent glioblastoma multiforme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Gamma knife surgery for glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Adverse radiation effects after Gamma Knife Surgery in relation to dose and volume.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

A simple method for predicting imaging-based complications following gamma knife surgery for cerebral arteriovenous malformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

MGMT gene silencing and benefit from temozolomide in glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Management of malignant glioma: steady progress with multimodal approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Measuring bias in uncontrolled brain tumor trials--to randomize or not to randomize?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Acute effects on neuropsychological function and quality of life by high-dose multiple daily fractionated radiotherapy for malignant astrocytomas: assessing the tolerability of a new radiotherapy regimen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

In regard to Dr. Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

The application of stereotactic radiosurgery to disorders of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Radiosurgery as part of the initial management of patients with malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Scale to predict survival after surgery for recurrent glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of recurrent glioblastoma multiforme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Re-operations of supratentorial anaplastic astrocytomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Evidence-based review of the role of reoperation in the management of malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

Reoperation for glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.03.024

10.1016/J.WNEU.2012.03.024

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

22484078

1 reference

13 February 2018